CA2492486A1 - Photometric determination of coagulation time in undiluted whole blood - Google Patents
Photometric determination of coagulation time in undiluted whole blood Download PDFInfo
- Publication number
- CA2492486A1 CA2492486A1 CA002492486A CA2492486A CA2492486A1 CA 2492486 A1 CA2492486 A1 CA 2492486A1 CA 002492486 A CA002492486 A CA 002492486A CA 2492486 A CA2492486 A CA 2492486A CA 2492486 A1 CA2492486 A1 CA 2492486A1
- Authority
- CA
- Canada
- Prior art keywords
- light
- coagulation
- sample
- blood
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000015271 coagulation Effects 0.000 title claims abstract description 193
- 238000005345 coagulation Methods 0.000 title claims abstract description 193
- 210000004369 blood Anatomy 0.000 title claims abstract description 159
- 239000008280 blood Substances 0.000 title claims abstract description 159
- 238000012360 testing method Methods 0.000 claims abstract description 86
- 238000006243 chemical reaction Methods 0.000 claims abstract description 72
- 238000000034 method Methods 0.000 claims abstract description 67
- 230000004520 agglutination Effects 0.000 claims abstract description 18
- 238000005259 measurement Methods 0.000 claims description 71
- 230000005540 biological transmission Effects 0.000 claims description 36
- 230000008859 change Effects 0.000 claims description 35
- 230000003287 optical effect Effects 0.000 claims description 29
- 238000004422 calculation algorithm Methods 0.000 claims description 18
- 239000007787 solid Substances 0.000 claims description 9
- 230000031700 light absorption Effects 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 6
- 230000002209 hydrophobic effect Effects 0.000 claims description 5
- 238000009529 body temperature measurement Methods 0.000 claims description 4
- 230000003204 osmotic effect Effects 0.000 claims description 4
- 238000007639 printing Methods 0.000 claims description 3
- 238000005375 photometry Methods 0.000 abstract description 28
- 238000001514 detection method Methods 0.000 abstract description 21
- 230000023555 blood coagulation Effects 0.000 abstract description 10
- 230000008901 benefit Effects 0.000 abstract description 8
- 230000000405 serological effect Effects 0.000 abstract description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 42
- 108010090444 Innovin Proteins 0.000 description 32
- 238000013459 approach Methods 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 14
- 108010000499 Thromboplastin Proteins 0.000 description 14
- 102000002262 Thromboplastin Human genes 0.000 description 14
- 150000003839 salts Chemical class 0.000 description 14
- 210000002381 plasma Anatomy 0.000 description 12
- 230000007423 decrease Effects 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 230000002123 temporal effect Effects 0.000 description 10
- 238000002834 transmittance Methods 0.000 description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 8
- 239000011575 calcium Substances 0.000 description 8
- 229910052791 calcium Inorganic materials 0.000 description 8
- 230000035602 clotting Effects 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 210000003743 erythrocyte Anatomy 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 5
- 108010094028 Prothrombin Proteins 0.000 description 5
- 102100027378 Prothrombin Human genes 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000005534 hematocrit Methods 0.000 description 5
- 229940039716 prothrombin Drugs 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 230000003321 amplification Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 229940127219 anticoagulant drug Drugs 0.000 description 4
- 239000004020 conductor Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229910052754 neon Inorganic materials 0.000 description 3
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000012935 Averaging Methods 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920004142 LEXAN™ Polymers 0.000 description 2
- 239000004418 Lexan Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000009795 derivation Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000006249 magnetic particle Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000004848 nephelometry Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 206010003178 Arterial thrombosis Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 241000694533 Recurvirostra Species 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 229920006266 Vinyl film Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 238000004555 blood preservation Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- -1 but not limited to Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000005253 cladding Methods 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000007820 coagulation assay Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000051 modifying effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- UPSFMJHZUCSEHU-JYGUBCOQSA-N n-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4r,5r,6s)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](NC(C)=O)[C@H](OC=2C=C3OC(=O)C=C(C)C3=CC=2)O[C@@H]1CO UPSFMJHZUCSEHU-JYGUBCOQSA-N 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000013643 reference control Substances 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000000790 scattering method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/27—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
- G01N21/272—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration for following a reaction, e.g. for determining photometrically a reaction rate (photometric cinetic analysis)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
- G01N21/03—Cuvette constructions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/82—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a precipitate or turbidity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/8483—Investigating reagent band
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4905—Determining clotting time of blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
- G01N21/03—Cuvette constructions
- G01N2021/0321—One time use cells, e.g. integrally moulded
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
- G01N21/03—Cuvette constructions
- G01N2021/0325—Cells for testing reactions, e.g. containing reagents
- G01N2021/0328—Arrangement of two or more cells having different functions for the measurement of reactions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
- G01N21/03—Cuvette constructions
- G01N2021/0346—Capillary cells; Microcells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/82—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a precipitate or turbidity
- G01N2021/825—Agglutination
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/02—Mechanical
- G01N2201/022—Casings
- G01N2201/0221—Portable; cableless; compact; hand-held
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/062—LED's
- G01N2201/0624—Compensating variation in output of LED source
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Mathematical Physics (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Plasma & Fusion (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Optical Measuring Cells (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42530002P | 2002-11-12 | 2002-11-12 | |
| US60/425,300 | 2002-11-12 | ||
| PCT/IL2003/000958 WO2004044560A1 (en) | 2002-11-12 | 2003-11-12 | Photometric determination of coagulation time in undiluted whole blood |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2492486A1 true CA2492486A1 (en) | 2004-05-27 |
Family
ID=32312967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002492486A Abandoned CA2492486A1 (en) | 2002-11-12 | 2003-11-12 | Photometric determination of coagulation time in undiluted whole blood |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060110283A1 (enExample) |
| EP (1) | EP1561094A4 (enExample) |
| JP (1) | JP2006505788A (enExample) |
| AU (1) | AU2003282351A1 (enExample) |
| CA (1) | CA2492486A1 (enExample) |
| WO (1) | WO2004044560A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108562559A (zh) * | 2018-01-18 | 2018-09-21 | 中实医疗科技江苏有限公司 | 全血凝固分析装置 |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7186566B2 (en) * | 2003-07-28 | 2007-03-06 | Suyue Qian | Combining transmittance detection and chromatographic strip techniques for quantification of analyte in biological fluids |
| US7815854B2 (en) | 2004-04-30 | 2010-10-19 | Kimberly-Clark Worldwide, Inc. | Electroluminescent illumination source for optical detection systems |
| US7796266B2 (en) | 2004-04-30 | 2010-09-14 | Kimberly-Clark Worldwide, Inc. | Optical detection system using electromagnetic radiation to detect presence or quantity of analyte |
| ES2342183T3 (es) * | 2005-08-31 | 2010-07-02 | Egomedical Technologies Ag | Sistema de ensayo de la coagulacion. |
| US20070285651A1 (en) * | 2006-04-24 | 2007-12-13 | Cantor Thomas L | Methods and devices for measuring sample coagulation |
| US8142722B2 (en) * | 2006-08-08 | 2012-03-27 | Hach Company | Test element and tester for analyzing solutions |
| WO2008081181A1 (en) | 2006-12-28 | 2008-07-10 | Highland Biosciences Limited | Biosensor |
| JP4528336B2 (ja) * | 2007-03-10 | 2010-08-18 | ローム アンド ハース カンパニー | 試験ストリップを読み取る方法 |
| EP2153211A4 (en) * | 2007-05-02 | 2012-03-14 | Fluidyx Pty Ltd | PORTABLE DEVICE FOR READING A CHIP ON A FLUORESCENT MARKING MEMBRANE |
| GB0716542D0 (en) * | 2007-08-24 | 2007-10-03 | Highland Biosciences Ltd | Endotoxin biosensor |
| EP2040073A1 (en) * | 2007-09-20 | 2009-03-25 | Iline Microsystems, S.L. | Microfluidic device and method for fluid clotting time determination |
| US9201059B2 (en) | 2008-03-14 | 2015-12-01 | Scandinavian Micro Biodevices Aps | Microfluidic system and a method of performing a test |
| US9562847B2 (en) * | 2008-04-04 | 2017-02-07 | Asmag-Holding Gmbh | Modular absorption measuring system |
| KR20100072612A (ko) | 2008-12-22 | 2010-07-01 | 한국전자통신연구원 | 측정 시작 시점 결정 장치가 구비된 측정 장치 |
| TWI461689B (zh) * | 2010-04-01 | 2014-11-21 | Univ Nat Cheng Kung | 含有乾粉狀試劑的血液凝固測試用生醫晶片 |
| ES2676846T3 (es) | 2010-08-05 | 2018-07-25 | Abbott Point Of Care, Inc. | Método y aparato para análisis automáticos de muestras de sangre completa a partir de imágenes microscópicas |
| EP2713878B1 (en) * | 2011-05-26 | 2021-07-07 | The General Hospital Corporation | Optical thromboelastography system and method for evaluation of blood coagulation metrics |
| JP5883314B2 (ja) * | 2011-09-02 | 2016-03-15 | 日本インスツルメンツ株式会社 | 還元気化水銀測定装置 |
| TWI468691B (zh) * | 2012-01-02 | 2015-01-11 | Univ Nat Cheng Kung | 血液凝固檢測裝置及方法 |
| KR101441359B1 (ko) * | 2012-01-16 | 2014-09-23 | 코닝정밀소재 주식회사 | 광전지용 커버유리의 투과율 측정장치 |
| FR2991457B1 (fr) * | 2012-06-01 | 2014-07-18 | Commissariat Energie Atomique | Procede et systeme de caracterisation de la vitesse de deplacement de particules contenues dans un liquide, telles que des particules sanguines |
| ES1077935Y (es) * | 2012-09-20 | 2013-01-30 | Software Tecnico Y Sectorial S L | Dispositivo portatil de analisis de contenido de sustancias en la sangre |
| US11172888B2 (en) | 2012-12-19 | 2021-11-16 | The General Hospital Corporation | Optical blood-coagulation sensor |
| US9297816B1 (en) | 2012-12-21 | 2016-03-29 | University Of South Florida | Devices and methods for measuring blood coagulation |
| WO2014121388A1 (en) * | 2013-02-06 | 2014-08-14 | Alentic Microscience Inc. | Detecting and using light representative of a sample |
| US9404794B2 (en) | 2013-02-28 | 2016-08-02 | Lifescan Scotland Limited | Ambient light compensation circuit for analyte measurement systems |
| FR3003033B1 (fr) * | 2013-03-07 | 2015-04-17 | Commissariat Energie Atomique | Dispositif de prelevement d'un echantillon de liquide par capillarite et procede d'analyse associe |
| US9529181B2 (en) | 2013-10-10 | 2016-12-27 | Nittoh Kogaku K.K. | Zoom lens system and imaging apparatus |
| TWI560437B (en) * | 2013-11-19 | 2016-12-01 | Univ Nat Tsing Hua | Fluorescence excitation device and portable fluorescence analysis system with the same |
| US9910251B2 (en) | 2014-03-19 | 2018-03-06 | Nittoh Inc. | Lens system and imaging apparatus having a lens at each side of an intermediate image which move in synchronization during focusing |
| JP6567549B2 (ja) * | 2014-04-30 | 2019-08-28 | インストゥルメンテーション ラボラトリー カンパニー | 光学検出によるポイントオブケア凝固アッセイのための方法及びシステム |
| US11484206B2 (en) | 2014-11-25 | 2022-11-01 | Ent. Services Development Corporation Lp | Implantable device for detecting light correlating to vessel |
| CN104897615A (zh) * | 2015-06-03 | 2015-09-09 | 何祖玲 | 智能血凝仪 |
| EP3538870B1 (en) | 2016-11-14 | 2024-09-04 | Siemens Healthcare Diagnostics Inc. | Methods and apparatus for characterizing a specimen using pattern illumination |
| AU2019347711B2 (en) | 2018-09-27 | 2022-04-14 | Siemens Healthcare Diagnostics Inc. | Multi-channel device for calculating coagulation characteristics of a patient's liquid test sample and methods of use related thereto |
| EP3941626A4 (en) | 2019-03-19 | 2022-07-20 | Siemens Healthcare Diagnostics, Inc. | <SUP2/>? <SUB2/>?1C?HBA-ASSAY SUPPORT AND METHOD FOR ITS PRODUCTION |
| CN112161955B (zh) * | 2020-07-22 | 2024-11-12 | 三诺生物传感股份有限公司 | 一种用于凝血四项的测试方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1209604B (it) * | 1984-11-27 | 1989-08-30 | Instrumentation Lab Spa | Metodo ed apparecchiatura per la misura di parametri di coagulazione. |
| US5164598A (en) * | 1985-08-05 | 1992-11-17 | Biotrack | Capillary flow device |
| DE3610429A1 (de) * | 1986-03-27 | 1987-10-01 | Boehringer Mannheim Gmbh | Gerinnungsneutrale, hydrophile glasfasern |
| JPS62226057A (ja) * | 1986-03-28 | 1987-10-05 | Minoru Tomita | 全血用赤血球の凝集率測定方法及びその装置 |
| US4849340A (en) * | 1987-04-03 | 1989-07-18 | Cardiovascular Diagnostics, Inc. | Reaction system element and method for performing prothrombin time assay |
| US5039617A (en) * | 1989-04-20 | 1991-08-13 | Biotrack, Inc. | Capillary flow device and method for measuring activated partial thromboplastin time |
| WO1993007492A1 (en) * | 1991-10-04 | 1993-04-15 | Baxter Diagnostics Inc. | Preparation of prothrombin time reagents from recombinant human tissue factor and purified natural and synthetic phospholipids |
| US5522255A (en) * | 1993-08-31 | 1996-06-04 | Boehringer Mannheim Corporation | Fluid dose, flow and coagulation sensor for medical instrument |
| US5418141A (en) * | 1994-05-06 | 1995-05-23 | Avocet Medical, Inc. | Test articles for performing dry reagent prothrombin time assays |
| AU689143B2 (en) * | 1994-12-02 | 1998-03-26 | Cardiovascular Diagnostics, Inc. | Improved method and analytical system for performing fibrinogen assays accurately, rapidly and simply |
| US6046051A (en) * | 1997-06-27 | 2000-04-04 | Hemosense, Inc. | Method and device for measuring blood coagulation or lysis by viscosity changes |
| US5986754A (en) * | 1997-12-08 | 1999-11-16 | Lifescan, Inc. | Medical diagnostic apparatus using a Fresnel reflector |
| US6165795A (en) * | 1998-06-25 | 2000-12-26 | Cardiovascular Diagnostics, Inc. | Methods for performing fibrinogen assays using dry chemical reagents containing ecarin and magnetic particles |
-
2003
- 2003-11-12 US US10/516,053 patent/US20060110283A1/en not_active Abandoned
- 2003-11-12 EP EP03773964A patent/EP1561094A4/en not_active Withdrawn
- 2003-11-12 WO PCT/IL2003/000958 patent/WO2004044560A1/en not_active Ceased
- 2003-11-12 CA CA002492486A patent/CA2492486A1/en not_active Abandoned
- 2003-11-12 JP JP2004551138A patent/JP2006505788A/ja not_active Withdrawn
- 2003-11-12 AU AU2003282351A patent/AU2003282351A1/en not_active Abandoned
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108562559A (zh) * | 2018-01-18 | 2018-09-21 | 中实医疗科技江苏有限公司 | 全血凝固分析装置 |
| CN108562559B (zh) * | 2018-01-18 | 2024-05-07 | 中实医疗科技江苏有限公司 | 全血凝固分析装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20060110283A1 (en) | 2006-05-25 |
| EP1561094A4 (en) | 2008-11-19 |
| EP1561094A1 (en) | 2005-08-10 |
| AU2003282351A1 (en) | 2004-06-03 |
| JP2006505788A (ja) | 2006-02-16 |
| WO2004044560A1 (en) | 2004-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20060110283A1 (en) | Photometric determination of coagulation time in undiluted whole blood | |
| CN109884289B (zh) | 低样本容量的凝血检测 | |
| AU2001271975B2 (en) | Method and apparatus for detecting the presence of a fluid on a test strip | |
| EP0308494B1 (en) | Element and method for performing a prothrombin time assay accurately, rapidly and simply | |
| CN100498336C (zh) | 定量测定未稀释未溶血全血中血红蛋白的方法 | |
| US7674616B2 (en) | Device and method for measuring properties of a sample | |
| CN101438144B (zh) | 用于血红蛋白定量确定的方法和系统 | |
| US7108966B2 (en) | Male fertility assay method and device | |
| US20050037511A1 (en) | Flow sensing for determination of assay results | |
| AU2001271975A1 (en) | Method and apparatus for detecting the presence of a fluid on a test strip | |
| CN1573315B (zh) | 用于判断化验结果的流量检测 | |
| WO2005108960A1 (ja) | センサ、測定装置および測定方法 | |
| US20080044842A1 (en) | Biological Test Strip | |
| CN101233407B (zh) | 测定仪器、测定装置和测定方法 | |
| AU617418B2 (en) | Apparatus for determination of the coagulation time of a blood sample | |
| JPH0875735A (ja) | 検体検査装置 | |
| TW202521964A (zh) | 具內部流道的尿液檢測裝置 | |
| GB2402473A (en) | Analyte assay reading device involving sample flow rate measurement | |
| WO1994017212A1 (en) | Slide immunoassay detection system | |
| HK40010174A (en) | Low-volume coagulation assay | |
| JPH0875732A (ja) | 検体検査装置 | |
| HK1139738B (en) | Flow sensing for determination of assay results |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |